371 related articles for article (PubMed ID: 6817759)
21. Determination of monoamine oxidase concentrations in rat liver by inhibitor binding.
Gomez N; Unzeta M; Tipton KF; Anderson MC; O'Carroll AM
Biochem Pharmacol; 1986 Dec; 35(24):4467-72. PubMed ID: 3790166
[TBL] [Abstract][Full Text] [Related]
22. The effect of selective monoamine oxidase inhibitors, clorgyline and deprenyl, upon tissue glycogen stores and blood glucose levels.
Ismahan G; Parvez H; Parvez S; Youdim MB
J Neural Transm Suppl; 1978; (14):143-52. PubMed ID: 290735
[TBL] [Abstract][Full Text] [Related]
23. Biochemical characterization of the active site of brain monoamine oxidase.
Youdim MB
Monogr Neural Sci; 1980; 7():176-92. PubMed ID: 6785574
[TBL] [Abstract][Full Text] [Related]
24. The monoamine oxidase B inhibitor deprenyl potentiates phenylethylamine behaviour in rats without inhibition of catecholamine metabolite formation.
Braestrup C; Andersen H; Randrup A
Eur J Pharmacol; 1975 Nov; 34(1):181-7. PubMed ID: 1241962
[TBL] [Abstract][Full Text] [Related]
25. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
Tadano T; Satoh S; Satoh N; Kisara K; Arai Y; Kim SK; Kinemuchi H
J Pharmacol Exp Ther; 1989 Jul; 250(1):254-60. PubMed ID: 2501477
[TBL] [Abstract][Full Text] [Related]
26. Clorgyline and deprenyl insensitive monoamine oxidase in rat brain soluble fraction.
Shekhar C; Mayanil K; Baquer NZ
Biochem Pharmacol; 1982 Dec; 31(23):3925-7. PubMed ID: 6818972
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of MAO-A activity enhances behavioural activity of rats assessed using water maze and open arena tasks.
Barbelivien A; Nyman L; Haapalinna A; Sirviö J
Pharmacol Toxicol; 2001 Jun; 88(6):304-12. PubMed ID: 11453370
[TBL] [Abstract][Full Text] [Related]
28. A model for the selective mode of action of the irreversible monoamine oxidase inhibitors clorgyline and deprenyl, based on studies of their ability to activate a Ca2+--Mg2+ ATPase in defined lipid environments.
Houslay MD
J Pharm Pharmacol; 1977 Nov; 29(11):664-9. PubMed ID: 22599
[No Abstract] [Full Text] [Related]
29. Effect of selective monoamine oxidase inhibitors on rat pineal melatonin synthesis in vitro.
Oxenkrug G; McIntyre I; McCauley R; Yuwiler A
J Pineal Res; 1988; 5(1):99-109. PubMed ID: 2452867
[TBL] [Abstract][Full Text] [Related]
30. Oxidation and enzyme-activated irreversible inhibition of rat liver monoamine oxidase-B by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Tipton KF; McCrodden JM; Youdim MB
Biochem J; 1986 Dec; 240(2):379-83. PubMed ID: 3101671
[TBL] [Abstract][Full Text] [Related]
31. The inhibition by clorgyline of 5-hydroxytryptamine deamination by the rat liver.
Fowler CJ; Callingham BA
J Pharm Pharmacol; 1978 May; 30(5):304-9. PubMed ID: 26745
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of metabolism dependent inhibition of CYP2B6 mediated bupropion hydroxylation in human liver microsomes by monoamine oxidase inhibitors and prediction of potential as perpetrators of drug interaction.
Nirogi R; Palacharla RC; Mohammed AR; Manoharan A; Ponnamaneni RK; Bhyrapuneni G
Chem Biol Interact; 2015 Mar; 230():9-20. PubMed ID: 25656918
[TBL] [Abstract][Full Text] [Related]
33. Thyroid iodide transport is reduced by administration of monoamine oxidase A inhibitors to rats.
Cabanillas AM; Masini-Repiso AM; Costamagna ME; Pellizas C; Coleoni AH
J Endocrinol; 1994 Nov; 143(2):303-8. PubMed ID: 7829993
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of rat brain cytosolic monoamine oxidase activity by clorgyline. Comparison with (-)-deprenyl and MDL 72145.
Azam M; Jain S; Baquer NZ
Biochem Pharmacol; 1990 Nov; 40(10):2215-8. PubMed ID: 2123104
[TBL] [Abstract][Full Text] [Related]
35. Molecular turnover numbers of different forms of mitochondrial monoamine oxidase in rat.
Egashira T; Ekstedt B; Kinemuchi H; Wiberg A; Oreland L
Med Biol; 1976 Aug; 54(4):272-7. PubMed ID: 957813
[TBL] [Abstract][Full Text] [Related]
36. Monoacylcadaverines as substrates for both monoamine oxidase and diamine oxidase; low rates of activity.
Suzuki O; Matsumoto T; Oya M; Katsumata Y; Stepita-Klauco M
Experientia; 1980 May; 36(5):535-7. PubMed ID: 6769699
[TBL] [Abstract][Full Text] [Related]
37. Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain.
Olmos G; Gabilondo AM; Miralles A; Escriba PV; García-Sevilla JA
Br J Pharmacol; 1993 Mar; 108(3):597-603. PubMed ID: 8385528
[TBL] [Abstract][Full Text] [Related]
38. Irreversible inhibition of rat liver mitochondrial MAO A and MAO B by enantiomers of deprenyl and alpha-methylpargyline.
Robinson JB; Bocchinfuso R; Khalil A
J Pharm Pharmacol; 1995 Apr; 47(4):324-8. PubMed ID: 7791031
[TBL] [Abstract][Full Text] [Related]
39. Differential trace amine alterations in individuals receiving acetylenic inhibitors of MAO-A (clorgyline) or MAO-B (selegiline and pargyline).
Murphy DL; Karoum F; Pickar D; Cohen RM; Lipper S; Mellow AM; Tariot PN; Sunderland T
J Neural Transm Suppl; 1998; 52():39-48. PubMed ID: 9564606
[TBL] [Abstract][Full Text] [Related]
40. Stereoselectivity and isoenzyme selectivity of monoamine oxidase inhibitors. Enantiomers of amphetamine, N-methylamphetamine and deprenyl.
Robinson JB
Biochem Pharmacol; 1985 Dec; 34(23):4105-8. PubMed ID: 3933519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
